Suciraslimab
Suciraslimab is a human IgG1 ?? monoclonal antibody targeting CD22. For optimal experimental control, it is recommended to use Human IgG1 kappa as an isotype control.
重要通知:仅供研究使用。我们不向患者销售。
Suciraslimab is a human IgG1 ?? monoclonal antibody targeting CD22. For optimal experimental control, it is recommended to use Human IgG1 kappa as an isotype control.
重要通知:仅供研究使用。我们不向患者销售。
Discription | Suciraslimab is a human IgG1 ?? monoclonal antibody targeting CD22. For optimal experimental control, it is recommended to use Human IgG1 kappa as an isotype control. |
||
---|---|---|---|
Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2